Zura Bio Limited (ZURA)

Zura Bio Statistics

Total Valuation

Zura Bio has a market cap or net worth of $249.02 million. The enterprise value is $90.63 million.

Market Cap	249.02M
Enterprise Value	90.63M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, before market open.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Zura Bio has 65.02 million shares outstanding. The number of shares has increased by 69.23% in one year.

Current Share Class	65.02M
Shares Outstanding	65.02M
Shares Change (YoY)	+69.23%
Shares Change (QoQ)	+1.43%
Owned by Insiders (%)	6.91%
Owned by Institutions (%)	40.95%
Float	37.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.86
P/TBV Ratio	1.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.40

Current Ratio	8.40
Quick Ratio	8.26
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.55% and return on invested capital (ROIC) is -29.07%.

Return on Equity (ROE)	-43.55%
Return on Assets (ROA)	-26.05%
Return on Invested Capital (ROIC)	-29.07%
Return on Capital Employed (ROCE)	-52.02%
Revenue Per Employee	n/a
Profits Per Employee	-$2.18M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.46% in the last 52 weeks. The beta is 0.25, so Zura Bio's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-20.46%
50-Day Moving Average	2.81
200-Day Moving Average	1.73
Relative Strength Index (RSI)	57.57
Average Volume (20 Days)	1,219,073

Short Selling Information

The latest short interest is 2.62 million, so 4.03% of the outstanding shares have been sold short.

Short Interest	2.62M
Short Previous Month	2.05M
Short % of Shares Out	4.03%
Short % of Float	6.92%
Short Ratio (days to cover)	0.70

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-72.37M
Pretax Income	-67.76M
Net Income	-65.43M
EBITDA	-72.34M
EBIT	-72.37M
Earnings Per Share (EPS)	-$0.72

Balance Sheet

The company has $154.49 million in cash and n/a in debt, giving a net cash position of $154.49 million or $2.38 per share.

Cash & Cash Equivalents	154.49M
Total Debt	n/a
Net Cash	154.49M
Net Cash Per Share	$2.38
Equity (Book Value)	139.11M
Book Value Per Share	2.03
Working Capital	138.29M

Cash Flow

In the last 12 months, operating cash flow was -$43.57 million and capital expenditures -$122,000, giving a free cash flow of -$43.69 million.

Operating Cash Flow	-43.57M
Capital Expenditures	-122,000
Free Cash Flow	-43.69M
FCF Per Share	-$0.67

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-69.23%
Shareholder Yield	-69.23%
Earnings Yield	-26.69%
FCF Yield	-17.82%

Analyst Forecast

The average price target for Zura Bio is $11.00, which is 187.21% higher than the current price. The consensus rating is "Buy".

Price Target	$11.00
Price Target Difference	187.21%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1